High VEGF signaling score tied to lung cancer prognosis

February 22, 2012
High VEGF signaling score tied to lung cancer prognosis
A high vascular endothelial growth factor signaling score correlates with good prognosis in patients with early squamous cell carcinoma of the lung, according to a study published online Feb. 21 in the Journal of Clinical Oncology.

(HealthDay) -- A high vascular endothelial growth factor (VEGF) signaling score correlates with good prognosis in patients with early squamous cell carcinoma (SCC) of the lung, according to a study published online Feb. 21 in the Journal of Clinical Oncology.

María J. Pajares, from the University of Navarra in Pamplona, Spain, and colleagues used automatic immunostaining to assess tumor cell expression of VEGF, VEGF receptor (VEGFR) 1, and VEGFR2 in 298 patients with early-stage nonsmall-cell lung cancer (NSCLC), recruited as part of the multicenter European Early Lung Cancer Detection Group project. By adding the tumor cell expression value of VEGF and its two receptors, they calculated a score measuring the VEGF signaling pathway. The results were validated in two independent NSCLC cohorts.

The researchers found that, in early SCC, the combination of high VEGF, VEGFR1, and VEGFR2 protein expression correlated with significantly reduced risk of disease progression (multivariate analysis hazard ratio, 0.62; P = 0.02). These results were validated, confirming the favorable prognostic value of high VEGF signaling score in early lung SCC.

"Our results clearly indicate that the combination of high expression of the three key elements in the VEGF pathway is associated with a good prognosis in patients with early SCC but not in patients with adenocarcinoma," the authors write.

Explore further: Stress and depression are associated with shorter survival in head and neck cancer patients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Researchers thwart cancer cells by triggering 'virus alert'

August 27, 2015

Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.